The estimated Net Worth of Kimberly Banks Mac Kay is at least $93.7 Mille dollars as of 22 February 2022. Ms Kay owns over 310 units of West Pharmaceutical Services stock worth over $93,729 and over the last 4 years she sold WST stock worth over $0.
Ms has made over 1 trades of the West Pharmaceutical Services stock since 2022, according to the Form 4 filled with the SEC. Most recently she exercised 310 units of WST stock worth $114,430 on 22 February 2022.
The largest trade she's ever made was exercising 310 units of West Pharmaceutical Services stock on 22 February 2022 worth over $114,430. On average, Ms trades about 62 units every 0 days since 2021. As of 22 February 2022 she still owns at least 310 units of West Pharmaceutical Services stock.
You can see the complete history of Ms Kay stock trades at the bottom of the page.
Kimberly Banks MacKay is the Sr. VP, Gen. Counsel & Company Sec. at West Pharmaceutical Services.
Ms MacKay is 55, she's been the Sr. VP e Gen. Counsel & Company Sec. of West Pharmaceutical Services since . There are 14 older and 11 younger executives at West Pharmaceutical Services. The oldest executive at West Pharmaceutical Services, Inc. is Patrick Zenner, 73, who is the Independent Chairman of the Board.
Kimberly's mailing address filed with the SEC is , 530 HERMAN O. WEST DRIVE, EXTON, PA, 19341.
Over the last 19 years, insiders at West Pharmaceutical Services have traded over $32,829,857 worth of West Pharmaceutical Services stock and bought 19,924 units worth $1,139,950 . The most active insiders traders include Robert F Friel, Paolo Pucci e Douglas A Michels. On average, West Pharmaceutical Services executives and independent directors trade stock every 40 days with the average trade being worth of $4,786,805. The most recent stock trade was executed by Charles Witherspoon on 19 August 2024, trading 1,029 units of WST stock currently worth $308,700.
west works side-by-side with healthcare partners from concept to the patient, designing and manufacturing packaging and delivery systems that promote efficiency, reliability and safety. west leads the way with cutting-edge technologies and quality systems, a thorough understanding of global regulatory compliance, and an unmatched knowledge of relevant pharmaceutical product testing, development and packaging. west supports customers from sales, manufacturing, and research and development locations in north and south america, europe, asia and australia.
West Pharmaceutical Services executives and other stock owners filed with the SEC include: